Effects of guideline adherent adjuvant treatment in primary breast cancer – A retrospective multi-center-cohort study of 3,976 patients

L. Schwentner, R. Wolters, M. Wischnewsky, R. Kreienberg & A. Wöckel
Background: The aim of that study was to analyze the impact of guideline adherent adjuvant treatment in early breast cancer on survival in a non-selected retrospective clinical cohort. Methods: A retrospective multi-center cohort study called BRENDA (‘breast cancer under evidence based guidelines’)[for full text, please go to the a.m. URL]